1st Quarter - Amendment — CEPHEID for CEPHEID (2009)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

CEPHEID

Client

CEPHEID

Income

—

Expenses

$60,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
1st Quarter - Report	Apr 20, 2009	$60,000	Replaced
1st Quarter - Report	Jul 15, 2009	$60,000	Replaced
1st Quarter - Amendment (this page)	Jul 15, 2009	$60,000	Replaced
1st Quarter - Amendment	Jul 15, 2009	$60,000	Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

See page 3 HR 1 American Recovery and Reinvestment Act of 2009 HR 805 / S 1028 Strengthening America's Public Health System Act H.R. 1105 FY 2009 Omnibus Appropriations Act HR 1321 Healthy Americans Act HR 1452 Medicare Clinical Diagnostic Laboratory Fee Schedule Modernization Act of 2009 HR 1699 / S 1220 Patient Access to Critical Lab Tests Act HR 2502 Comparative Effectiveness Research Act of 2009 HR 2824 Doctor-Patient Relationship and Research Protection Act HR 2937/ S 1305 MRSA Infection Prevention and Patient Protection Act HR 3104 Healthy Hospitals Act of 2009 HR 3002 / S 1259 PATIENTS Act of 2009 S 1208 Strengthening America's Public Health System Act S 1213 Patient-Centered Outcomes Research Act of 2009 S 1220 Patient Access to Critical Lab Tests Act S 1299 Worker Infection Protection Act

Lobbyist	Covered position, as disclosed
HALLIE CHRISTINE LEWIS	Manager, Government Relations
MICHELE M SCHOONMAKER	Director, Government Affairs

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); SENATE; Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 3104 (111th), H.R. 2502 (111th), H.R. 2937 (111th), H.R. 1 (111th), H.R. 3002 (111th), H.R. 1105 (111th), H.R. 1452 (111th), H.R. 1699 (111th), H.R. 1321 (111th), H.R. 2824 (111th), H.R. 805 (111th)

Medical/Disease Research/Clinical Labs MED

See page 5 HR 1 American Recovery and Reinvestment Act of 2009 HR 805 / S 1028 Strengthening America's Public Health System Act H.R. 1105 FY 2009 Omnibus Appropriations Act HR 1321 Healthy Americans Act HR 1452 Medicare Clinical Diagnostic Laboratory Fee Schedule Modernization Act of 2009 HR 1699 / S 1220 Patient Access to Critical Lab Tests Act HR 2502 Comparative Effectiveness Research Act of 2009 HR 2824 Doctor-Patient Relationship and Research Protection Act HR 2937/ S 1305 MRSA Infection Prevention and Patient Protection Act HR 3104 Healthy Hospitals Act of 2009 HR 3002 / S 1259 PATIENTS Act of 2009 S 1208 Strengthening America's Public Health System Act S 1213 Patient-Centered Outcomes Research Act of 2009 S 1220 Patient Access to Critical Lab Tests Act S 1299 Worker Infection Protection Act

Lobbyist	Covered position, as disclosed
HALLIE CHRISTINE LEWIS	Manager, Government Relations
MICHELE M SCHOONMAKER	Director, Government Affairs

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH)

Bills named: H.R. 1 (111th), H.R. 1452 (111th), H.R. 805 (111th), H.R. 1321 (111th), H.R. 2937 (111th), H.R. 2824 (111th), H.R. 1699 (111th), H.R. 2502 (111th), H.R. 3002 (111th), H.R. 3104 (111th), H.R. 1105 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.